FDA Inspection 1157271 — Kaiser Permanente Center For Reproductive Health

Kaiser Permanente Center For Reproductive Health — FEI 3006304159

The FDA completed an inspection of Kaiser Permanente Center For Reproductive Health on November 17, 2021 in Sacramento, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 17, 2021
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Sacramento, CA (United States)